OTC Pharmaceuticals - Uzbekistan | Statista Market Forecast

Revenue in the OTC Pharmaceuticals market amounts to US$354.10m in 2024. The market is expected to grow annually by 12.87% (CAGR 2024-2029).
The market's largest segment is the segment Analgesics with a market volume of US$96.97m in 2024.
In global comparison, most revenue is generated United States (US$41bn in 2024).
In relation to total population figures, per person revenues of US$9.93 are generated in 2024.
In the OTC Pharmaceuticals market, 0.8% of total revenue will be generated through online sales by 2024.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Uzbekistan is witnessing significant growth and development in recent years.

Customer preferences: Customers in Uzbekistan are increasingly opting for over-the-counter (OTC) pharmaceutical products due to several factors. Firstly, the convenience and accessibility of OTC medicines make them a popular choice among consumers. They can be purchased without a prescription, saving time and effort for individuals seeking relief from common ailments. Additionally, the affordability of OTC medications compared to prescription drugs is another driving factor behind customer preferences.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in Uzbekistan is the increasing demand for preventive healthcare products. Consumers are becoming more proactive in managing their health and are seeking OTC products that can help prevent illnesses and promote overall well-being. This trend is fueled by a growing awareness of the importance of self-care and personal health maintenance. As a result, there is a rising demand for vitamins, dietary supplements, and other preventive healthcare products in the market. Another trend in the market is the growing popularity of herbal and natural remedies. Consumers are increasingly seeking alternative treatments and are turning to traditional herbal medicines for various health conditions. This trend is driven by a desire for natural and holistic approaches to healthcare, as well as a preference for products with fewer side effects. As a result, there is a surge in the demand for herbal OTC products in Uzbekistan.

Local special circumstances: Uzbekistan has a well-established pharmaceutical industry, with a number of domestic manufacturers producing OTC medicines. This has led to a wide range of locally produced OTC products being available in the market. The presence of local players not only ensures a steady supply of affordable OTC medications but also contributes to the overall growth of the market. Additionally, the government of Uzbekistan has been actively promoting the use of OTC medicines as part of its healthcare policies, which further supports the development of the market.

Underlying macroeconomic factors: The OTC Pharmaceuticals market in Uzbekistan is benefiting from favorable macroeconomic factors. The country has been experiencing steady economic growth, which has resulted in an increase in disposable incomes and improved living standards. As a result, consumers have more purchasing power and are willing to spend on healthcare products, including OTC medicines. Furthermore, the government's efforts to improve the healthcare infrastructure and increase access to healthcare services have also contributed to the growth of the OTC Pharmaceuticals market. In conclusion, the OTC Pharmaceuticals market in Uzbekistan is witnessing significant growth and development, driven by customer preferences for convenience, affordability, and preventive healthcare products. The market is also influenced by trends such as the demand for herbal and natural remedies. Local special circumstances, including a well-established pharmaceutical industry and government support, further contribute to the market's growth. Favorable macroeconomic factors, such as economic growth and improved living standards, also play a role in the development of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Consumer market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.